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Background: With the recent widespread use of endobronchial ultrasound-guided transbronchial needle aspiration
(EBUS-TBNA), there have been occasional reports on complications associated with its use. Previous reviews on
EBUS-TBNA have been limited to studies by skilled operators, thus the results may not always be applicable to
recent clinical practice. To assess the safety of EBUS-TBNA for the staging and diagnosis of lung cancer in Japan, a
nationwide survey on its current usage status and complications associated with its use was conducted by the
Japan Society for Respiratory Endoscopy (JSRE).
Methods: A questionnaire about EBUS-TBNA performed between January 2011 and June 2012 was mailed to 520
JSRE-accredited facilities.
Results: Responses were obtained from 455 facilities (87.5%). During the study period, EBUS-TBNA was performed
in 7,345 cases in 210 facilities (46.2%) using a convex probe ultrasound bronchoscope, for 6,836 mediastinal and
hilar lesions and 275 lung parenchymal lesions. Ninety complications occurred in 32 facilities. The complication rate
was 1.23% (95% confidence interval, 0.97%-1.48%), with hemorrhage being the most frequent complication (50 cases,
0.68%). Infectious complications developed in 14 cases (0.19%) (Mediastinitis, 7; pneumonia, 4; pericarditis, 1; cyst
infection, 1; and sepsis, 1). Pneumothorax developed in 2 cases (0.03%), one of which required tube drainage.
Regarding the outcome of the cases with complications, prolonged hospitalization was observed in 14 cases, life-
threatening conditions in 4, and death in 1 (severe cerebral infarction) (mortality rate, 0.01%). Breakage of the
ultrasound bronchoscope occurred in 98 cases (1.33%) in 67 facilities (31.9%), and that of the puncture needle in 15
cases (0.20%) in 8 facilities (3.8%).
Conclusions: Although the complication rate associated with EBUS-TBNA was found to be low, severe complications,
including infectious complications, were observed, and the incidence of device breakage was high. Since the use of
EBUS-TBNA is rapidly expanding in Japan, an educational program for its safe performance should be immediately
established.
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Endobronchial ultrasound-guided transbronchial needle
aspiration (EBUS-TBNA) performed using a convex
probe ultrasound bronchoscope is a minimally invasive
diagnostic method for peritracheal and peribronchial le-
sions [1]. EBUS-TBNA enables the accurate collection of
samples from the lesion since the puncture site can be
confirmed under real-time ultrasound guidance, allowing
cytological and histological diagnosis. In the lymph node
staging of lung cancer, EBUS-TBNA has a cumulative
sensitivity of 88%-93% and a cumulative specificity of
100% [2,3]. For the diagnosis of mediastinal lymph node
metastasis of lung cancer, mediastinoscopy is convention-
ally considered as the gold standard [4]. However, com-
pared with surgical diagnosis using a mediastinoscope or
thoracoscope, EBUS-TBNA and transesophageal endo-
scopic ultrasound with fine needle aspiration (EUS-FNA)
followed by surgical diagnosis have been reported to in-
crease the diagnostic rate [5]. EBUS-TBNA alone has a
diagnostic rate similar to that of mediastinoscopy [6,7]. In
addition, the introduction of EBUS-TBNA has resulted in
cost benefit in terms of minimally invasive lung cancer
staging [8,9]. Hence, EBUS-TBNA has effectively been re-
placing mediastinoscopy for the staging of lung cancer
and in establishing a definitive diagnosis of mediastinal
and hilar lymphadenopathy owing to its high diagnostic
rate, minimal invasiveness, and cost benefit. EBUS-TBNA
has also an extremely low complication rate and is there-
fore considered to be safe and minimally invasive [2,10].
However, there have been occasional reports on compli-
cations with the recent widespread use of EBUS-TBNA
[11-14]. Moreover, previous reviews on EBUS-TBNA have
been limited to studies by skilled operators, and thus the
results may not always be applicable to recent clinical
practice. Previous reviews particularly on the cost benefit
of EBUS-TBNA have not included the repair cost for
damaged EBUS-TBNA instruments. As EBUS-TBNA will
increasingly be used for the staging and diagnosis of lung
cancer, accompanying severe complications may also
increase. Damage to EBUS-TBNA instruments not only
poses a problem with regard to the cost benefit, but also
threatens the safety and effectiveness of the procedure. To
assess the safety of EBUS-TBNA for the staging and diag-
nosis of lung cancer in Japan, a nationwide survey on its
current usage status and complications associated with its
use was conducted by JSRE.
Methods
This study was a nationwide, retrospective questionnaire
survey approved by JSRE. In July 2012, a JSRE-approved
questionnaire was mailed to 520 JSRE-accredited facil-
ities and affiliated facilities throughout Japan. The ques-
tionnaire (an additional data file shows this in more
detail [see Additional file 1]) included specific questionsregarding the number of cases examined by EBUS-
TBNA, the characteristics of the cases, and the compli-
cations of EBUS-TBNA performed using a convex probe
ultrasound bronchoscope during the preceding 18
months (January 2011 through June 2012). Details re-
garding the complications were obtained by asking ques-
tions about patient background, procedural factors, and
outcomes using an exclusive case report form. A mark
sheet selection system was used, except for some items
that were to be described using free text. As a rule, a
JSRE-accredited senior fellow representing each institu-
tion provided the responses to the questionnaire. The
number of cases, number of cases with complications,
and details of cases showing complications were
reported by the same senior fellow, based on the medical
records in each institution. The investigated complica-
tions included hemorrhage that required treatments
other than aspiration, compression and cold physio-
logical saline injection (massive hemorrhage was defined
as a blood loss of ≥ 300 mL or that requiring blood
transfusion), pneumonia, mediastinitis, pericarditis,
other infectious complications, pneumothorax requiring
bed rest or thoracic drainage, lidocaine intoxication re-
quiring special intervention because of convulsions/loss
of consciousness, bronchial asthma, respiratory failure
(excluding patients treated by oxygen administration
alone), and complications related to the circulatory sys-
tem requiring special treatment, among others. Compli-
cations due to procedures performed simultaneously
with EBUS-TBNA, such as forceps biopsy or bronchoal-
veolar lavage, were excluded.
Results were automatically collected using a computer.
For multiple-choice questions permitting only 1 re-
sponse, no response to the question was regarded as an
invalid response. All proportions were expressed as a
percentage of the number of valid responses. Results
were analyzed using a standard statistical method with
the SAS system for Windows release 9.3 (SAS Institute
Inc., Cary, NC, USA).
Results
Responses were obtained from 455 facilities (response
rate, 87.5%).
Number of cases
EBUS-TBNA performed using a convex probe was car-
ried out in 7,345 cases in 210 facilities (46.2%) out of the
455 facilities that responded. The indications of the pro-
cedure (multiple selections allowed) were for the estab-
lishment of a diagnosis in 5,855 cases (suspected lung
cancer in 4,304 cases, suspected malignant lymphoma in
321 cases, suspected sarcoidosis in 988 cases, and others
in 527 cases; multiple selections allowed) and the staging
of lung cancer in 1,850 cases. The lesion was located in
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lung parenchyma in 275 cases (Table 1). EBUS-TBNA
was performed by JSRE-accredited non-fellows in 3,442
cases (46.9%) and JSRE-accredited fellows in 3,896 cases
(53.1%); no information regarding the operators was
given in 7 cases.Complications
Complications developed in 90 cases (1.23%; 95% confi-
dence interval (CI), 0.97%-1.48%) in 32 facilities (15.2%).
For complications, hemorrhage was observed in 50 cases
(0.68%; 95% CI, 0.49%-0.87%) including 1 case of massive
hemorrhage. Mediastinitis developed in 7 cases (0.10%;
95% CI, 0.02%-0.17%), pneumonia in 4 cases (0.05%), peri-
carditis in 1 case (0.01%), cyst infection in 1 case (0.01%),
and sepsis in 1 case (0.01%). Infectious complications
(mediastinitis, pneumonia, pericarditis, cyst infection and
sepsis) occurred in 14 cases (0.19%; 95% CI, 0.09%-0.29%).
Respiratory failure developed in 5 cases (0.07%). Lidocaine
toxicity was observed in 4 cases (0.05%). Pneumothorax
was observed in 2 cases (0.03%), 1 of which required tube
drainage. Bronchial asthmatic attack was observed in 1
case (0.01%). As for cardiovascular events, arrhythmia
developed in 3 cases (0.04%) and hypotension in 1 case
(0.01%). Regarding other complications, fever was ob-
served in 4 cases (0.05%), cerebral infarction in 2 cases
(0.03%), aggravation of airway obstruction in 2 cases
(0.03%), tumor rupture in 1 case (0.01%), and hyperven-
tilation syndrome in 1 case (0.01%).Reports of cases with complications
There were reports of 79 cases with complications. The
background, procedural factors, and outcomes of these
cases are described below.Table 1 Total number of EBUS-TBNA procedures
performed according to indication and target lesion
Total
number
Respondents Mean Median Range




5,855 207 28.3 16 1-223
Lung cancer
staging




6,836 209 32.7 17 1-235
Lesions in lung
parenchyma
275 68 4.0 2 1-22
EBUS-TBNA, endobronchial ultrasound-guided transbronchial
needle aspiration.Patient background
The median age of the patients was 69 years (25–87
years). There were 59 men (75.6%) and 19 women
(24.4%), with 1 patient whose sex was undisclosed. The
targets for puncture were the hilar and mediastinal
lymph nodes in 76 cases (96.2%) and lesions in the lung
parenchyma in 3 cases (3.8%). The complication rates
were 1.11% and 1.09%, respectively, with no statistically
significant difference in the complication rates between
the target lesions (p > 0.999; Fisher exact test).
Background of operators
The operators were JSRE-accredited non-fellows in 46
cases (58.2%) and JSRE-accredited fellows in 33 cases
(41.8%). The complication rate was 1.34% for JSRE-
accredited non-fellows and 0.85% for JSRE-accredited
fellows (p = 0.0535; Fisher exact test), being slightly
higher in the former. In the patients who developed
EBUS-TBNA-related complications, the operators had
the following EBUS-TBNA experience before the occur-
rence of complications: fewer than 5 cases in 8 patients
(10.3%), 5–19 cases in 17 patients (21.8%), 20–49 cases
in 43 patients (55.1%), and more than or equal to 50
cases in 10 patients (12.8%); there was no description re-
garding the background of the operator in 1 case. The
operators had attended a hands-on training course in 41
cases (52.6%) and had not attended a hands-on training
course in 37 (47.4%) cases; there was no information
whether the operator attended a hands-on training
course in 1 case.
Procedural factors
Sixty-once cases received intravenous sedation (79.2%)
whereas 16 cases (20.8%) did not receive intravenous
sedation during the procedure. There was no informa-
tion regarding intravenous sedation during the proced-
ure for 2 cases. A 22-gauge needle was used in 53 cases
(76.8%) and a 21-gauge needle was used in 16 cases
(23.2%); there was no description about the needle gauge
used in 10 cases. The number of lymph nodes punctured
was 1 in 59 cases (76.6%) and 2 in 18 cases (23.4%);
there was no information about puncture number in 2
cases. The maximum short-axis diameter of the punc-
tured lymph node was from 5 to < 10 mm in 4 cases
(5.8%) and ≥ 10 mm in 65 cases (94.2%); there was no
description given in 10 cases. The most frequently punc-
tured lymph node was #7 in 34 patients (43.0%),
followed by #4R in 24 patients (30.4%). The total number
of punctures was 1 in 32 cases (41.6%), 2 in 26 cases
(33.8%), 3 in 9 cases (11.7%), 4 in 9 cases (11.7%), and ≥ 5
in 1 case (1.3%); there was no description available in 2
cases. On-site cytodiagnosis was performed in 27 cases
(35.1%) and not performed in 50 cases (64.9%); there was
no description given in 2 cases.
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diagnosis could be made in 58 cases (76.3%) but not in
18 cases (23.7%; non-diagnostic cases: diagnosis could
not be made based on the EBUS-TBNA findings); there
was no description provided in 3 cases. The final diagno-
sis based on the surgical findings and clinical course, in
addition to the EBUS-TBNA findings, was lung cancer
in 49 cases (66.2%), metastatic lung tumor in 3 cases
(4.1%), malignant lymphoma in 2 cases (2.7%), other ma-
lignant tumors in 3 cases (4.1%), sarcoidosis in 3 cases
(4.1%), other benign diseases in 8 cases (10.8%), and in-
definite (the final diagnosis could not be made using any
methods including EBUS-TBNA or observation of the
clinical course) in 6 cases (8.1%); there was no descrip-
tion given in 5 cases.
Outcomes
Complication-induced adverse events were absent in 57
cases that developed complications (75.0%). Hospitalization
was prolonged in 14 cases (18.4%) because of pneumonia
in 4 cases, respiratory failure in 3 cases, hemorrhage in 2
cases, mediastinitis in 1 case, pneumothorax in 1 case,
bronchial cyst infection in 1 case, fever in 1 case, and cere-
bral infarction in 1 case. Life-threatening consequences of
the following complications were observed in 4 cases
(5.3%): mediastinitis, 2 cases; tumor rupture, 1 case; and
aggravation of airway stenosis, 1 case. Death due to cere-
bral infarction was observed in 1 case (1.3%). The mortality
rate was 0.01%. There was no description of adverse events
in 3 cases.
Characteristics of each complication
Hemorrhage was observed in 42 cases, of which 1 patient
showed massive hemorrhage. In this case, hemorrhage
after the puncture of lymph node #11L, possibly due to
damage of the blood vessels, required prolongation of
hospitalization. None of the 42 cases were being treated
with antiplatelet drugs; 4 cases (22.2%) were in a drug
withdrawal period, and no antiplatelet drug had been used
in 14 cases (77.8%). There was no description available in
24 cases.
The maximum short-axis diameter of the punctured
lymph node was from 5 to <10 mm in 2 cases (5.9%)
and ≥10 mm in 32 cases (94.1%); there was no descrip-
tion regarding this in 8 cases. The most frequently punc-
tured lymph node was #7 in 34 patients (43.0%),
followed by #4R in 24 patients (30.4%). The total num-
ber of punctures was 1 in 24 cases (57.1%), 2 in 14 cases
(33.3%), 3 in 1 case (2.4%), and 4 in 3 cases (7.1%). A 22-
gauge needle was used in 30 cases (85.7%) and a 21-gauge
needle was used in 5 cases (14.3%) with hemorrhage; there
was no description given in 7 cases.
The operator was a JSRE-accredited non-fellow in 26
cases (61.9%) and a JSRE-accredited fellow in 16 cases(38.1%). In patients who developed EBUS-TBNA-related
complications, the operators had the following EBUS-
TBNA experience before the occurrence of complica-
tions: 5–19 cases in 5 patients (11.9%), 20–49 cases in
32 patients (76.2%), and ≥ 50 cases in 5 patients (11.9%).
Mediastinitis was observed in 7 cases, of which only 1
had diabetes mellitus as an underlying disease. The
punctured lymph node was #4R in 4 and #7 in 3 of the
mediastinitis cases. Ultrasound findings at the puncture
site of the 7 cases suggested necrotic areas in 2 cases
(33.3%), other than necrosis or cysts in 2 cases (33.3%), and
unclear in 2 cases (33.3%); there was no description in 1
case. In 11 (84.6%) of 14 cases showing infectious compli-
cations, no prophylactic antibiotic had been administered.
In the 2 cases developing pneumothorax, 5 punctures
of lymph nodes #4R and #7 and 4 punctures of lymph
node #4L had been performed. In a case showing asth-
matic attacks, although there was a history of bronchial
asthma, no prophylactic bronchodilator had been ad-
ministered before examination. Two cases showed cere-
bral infarction during the antiplatelet drug withdrawal
period. One of these cases showed bilateral stenosis of
the internal carotid arteries and replacement of the anti-
coagulant with heparin. This patient died of thrombotic
occlusion of these arteries after completion of the exam-
ination. The case of tumor rupture, which was con-
firmed by surgery, involved a mediastinal tumor in
which pleural hemorrhage occurred after EBUS-TBNA.
Breakage of EBUS-TBNA instruments
During the investigation period, the ultrasound broncho-
scope used was damaged in 98 cases (1.33%; 95% CI,
1.07%-1.60%) in 67 facilities (31.9%) (Table 2). Regarding
the damaged part, breakage of the working channel for
needle insertion was found in 71 cases (74.0%), breakage
of the fiber owing to external compression, such as bit-
ing by the patient, occurred in 15 cases (15.6%), break-
age of the ultrasound probe in 7 cases (7.3%), and
breakage of other portions in 3 cases (3.1%); there was
no description available in 2 cases. Breakage of the punc-
ture needle occurred in 15 cases (0.20%; 95% CI, 0.10%-
0.31%) in 8 facilities (3.8%).
Discussion
To the best of our knowledge, this is the first nationwide
survey describing in detail the complications associated
with the use of EBUS-TBNA. As this survey was admin-
istered by a scientific society, and the obtained response
rate to the questionnaire was considerably high (87.5%),
the results may effectively reflect the present status of
the use of and complications associated with EBUS-
TBNA in Japan. A previous questionnaire survey
performed in Japan in 2010 showed that 143 facilities
nationwide owned and used EBUS-TBNA devices [15].




Respondents Mean Median Range
Site of damage:
Bronchoscopes 98 67 1.46 1 1-5
Working
channel
71 50 1.42 1 1-4
Fiber portion 15 15 1 1 1
US probe 7 7 1 1 1
Other
portions
3 2 1.33 1 1-2
Puncture needle 15 8 1.63 1 1-4
EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle
aspiration; US, ultrasound.
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year period. The number of cases examined using
EBUS-TBNA per year, as calculated from the number of
questionnaires recovered, was 4,108 cases in a previous
survey and 5,596 in the present survey, indicating an
approximately 1.4-fold increase in the number of EBUS-
TBNA performed per year.
Previous meta-analyses of conventional TBNA showed a
major complication rate of 0.3% [16]. Massive hemorrhage,
pneumomediastinum, pneumothorax requiring drainage,
cardiac tamponade, and hemomediastinum have all been
reported as TBNA complications [16,17]. A meta-analysis
of EBUS-TBNA showed a complication rate of 2 in 1,299
cases (0.15%), with only 1 case showing pneumothorax re-
quiring drainage as a major complication [2]. However, the
studies evaluated by this meta-analysis had been performed
in facilities with skilled operators. With the recent wide-
spread use of EBUS-TBNA, complications have occasion-
ally been reported [11-14]. A survey in 2010 showed a
complication rate of 0.46% for EBUS-TBNA [18]. On the
other hand, a prospective study by Eapen et al. revealed a
complication rate of 1.44% [19]. The incidence of com-
plications differs and depends not only among medical
examination/treatment environments, but also on the
definitions of the complications. The definitions of the
different complications assessed in this study were the
same as those in the 2010 survey, except for
hemorrhage. In the present survey, a broader definition
of hemorrhage was used compared with the previous
survey, and hemorrhage that required treatment was
also included in the list of complications. This possibly
accounted for the higher complication rate in the
present study. Furthermore, the incidence of the differ-
ent types of complications in the present survey dif-
fered from that reported by Eapen et al. [19]. In the
present survey, the incidence of pneumothorax was low
but that of infectious complications was high. This may
have been due to not only differences in the medicalexamination/treatment environments between Japan and
the U.S. as well as differences in the survey methods, but
also the evaluation of only complications developing
within 24 hours and the inclusion of complications due to
other procedures such as transbronchial biopsy that were
simultaneously performed in the survey by Eapen et al.
The complication rate in this survey was lower than that
using mediastinoscopy (2.5%) [20] or other bronchoscopic
diagnostic methods [18], demonstrating the safety of
EBUS-TBNA.
However, in the present study, death or life-threatening
consequences were observed in 5 cases. In addition, the
incidence of infectious complications was high. Regarding
infectious complications, mediastinitis [12,13], pericarditis
[11], and tumor infection [11] have been reported, each of
which is a severe condition requiring broad-spectrum an-
tibiotics and surgical procedures such as drainage. Two
cases in the present study were considered to have life-
threatening conditions. As for the possible causes of in-
fectious complications, cross-contamination, leading to
mediastinal inoculation by oral and nasopharyngeal
commensals [11,13], and nosocomial infection due to
inappropriate bronchoscope disinfection or mishand-
ling of devices [12] have been reported. Previous stud-
ies have suggested that these infectious complications
are not caused by hematogenous seeding due to
bacteremia, but by spread from the puncture site [13].
When the puncture site is necrotic or cystic, blood flow
is slight, resistance is decreased, and bacterial attach-
ment clearance is decreased [11]. To prevent this con-
dition, the location of the needle tip should be
confirmed by ultrasonography at the time of puncture,
and the lesion should be accurately punctured [11]. As
in EUS-FNA, the puncture of necrotic [21] or cystic
areas [22] should be avoided. Unlike conventional
TBNA, lesions are punctured with a puncture needle
containing a stylet in EBUS-TBNA. Since infection may
be caused by operating the stylet, it should be handled
aseptically when multiple punctures are applied. Disin-
fection of devices according to the guidelines [23] and
careful observation of the postprocedure course for
signs of infection are important. However, prophylactic
antibiotic administration is not recommended in rou-
tine diagnostic bronchoscopy, except for certain dis-
eases [24]. In the present study, there were no clearly
immunocompromised patients with infectious compli-
cations, and prophylactic antibiotics were not administered
in 11 of the 14 cases showing infectious complications.
Further studies are necessary to evaluate the need for
prophylactic antibiotic administration and to identify the
cases requiring such prophylaxis. In particular, Eapen et al.
reported patients who died of hemorrhage [19]. In the
present study, only 1 case showed massive hemorrhage
caused by perforation of a minor blood vessel in the lymph
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ture of the pulmonary artery [14] without symptoms and
detected by echography or contrast CT. Thus, the inci-
dence of erroneous puncture of a major vessel may be
higher than that of massive hemorrhage as a complication.
Hence, it is important to know the anatomy around the
puncture area and to accurately puncture only the lesion.
Bronchial asthma, cerebral infarction, and lidocaine intoxi-
cation were considered to be complications of the bron-
choscopic procedure. In patients at risk, procedures
following the guidelines are necessary, including prophy-
lactic bronchodilator administration, continuation of
antiplatelet drugs/anticoagulants or drug replacement de-
pending on the underlying diseases and drug composition,
adequate assessment of the indications for examination,
and observance of the maximum lidocaine dose that can
be safely administered [24].
In the present study, the complication rate was slightly
higher in the procedures performed by JSRE-accredited
non-fellows than in those performed by JSRE-accredited
fellows. Regarding the diagnostic rate, a prospective
study previously showed that high-volume hospitals had
high diagnostic yields, and that biopsy was performed on
more nodes including smaller nodes [25]. Although
Eapen et al. stated that safety is not associated with ex-
perience [19], their data were, however, obtained from
tertiary care hospitals. Therefore, we cannot exclude the
possibility that the complication and diagnosis rates dif-
fer among facilities and according to the operator’s ex-
perience. In EBUS-TBNA, the learning speed varies even
among skilled bronchoscopists [26]. Moreover, the num-
ber of cases that must be performed to be able to carry
out EBUS-TBNA safely and to achieve an adequate diag-
nostic rate is difficult to determine. The guidelines of the
American College of Chest Physicians [27], European
Respiratory Society/American Thoracic Society [28], and
Thoracic Society of Australia and New Zealand [29] indi-
cate that 50 (radial probe), 40 (convex and radial probe),
and 20 cases, respectively, are necessary for this purpose,
and that EBUS-TBNA must be performed in 25, 20, and
20 cases per year, respectively, to maintain EBUS-TBNA
competency. The present survey did not include the num-
ber of patients undergoing EBUS-TBNA by operators with
no experience of complications, and thus the complication
rate according to the number of cases experienced by the
operators could not be determined. Accordingly, the num-
ber of cases experienced which are necessary to acquire
the skill to safely perform EBUS-TBNA is unclear. Most
of the operators in the present study had experienced less
than 50 EBUS-TBNA cases at the time of the occurrence
of complications, and about 50% of the operators had
never attended any hands-on training. At present, con-
crete instructions and educational methods are left to the
judgment of each institution, and they vary amongfacilities. Experienced bronchoscopists, such as JSRE-
accredited fellows in each institution, should receive
hands-on training in the course authorized by JSRE in
order to become supervisors of EBUS-TBNA. A common
learning system [30] and an evaluation method across fa-
cilities using objective parameters of skills [31] should be
immediately established and applied to enable EBUS-
TBNA operators to receive optimal training under the
instruction of qualified supervisors. In addition, useful
simulation trainings [32] and their active incorporation
into the learning system should also be considered.
With regard to device breakage, this has been infre-
quently reported [33]. In the present study, the breakage
rate for EBUS-TBNA bronchoscopes and devices was
1.54%, which was significantly higher (p < 0.001, Fisher
exact test) than that in all bronchoscopy procedures
(0.77%) in the 2010 survey [18]. Breakage most com-
monly occurred in the working channel mostly due to
the needle perforation of the working channel. Proper
placement of the puncture needle in the sheath and its
blockage should be confirmed before insertion and re-
moval of the puncture needle. Tremblay et al. reported
that the repair cost of EBUS-TBNA instruments for each
patient is higher than that of the bronchoscope used for
conventional flexible bronchoscopy. In the present sur-
vey, EBUS-TBNA was not performed in 245 facilities,
possibly because of the lack of EBUS-TBNA instruments
in most of these facilities [15]. Unlike conventional
TBNA, EBUS-TBNA is complex and requires hands-on
training. Moreover, EBUS-TBNA instruments are expen-
sive, and their maintenance and repair costs are high be-
cause of their high damage rate, which may be obstacles
to the introduction of EBUS-TBNA.
The present study has several limitations. Recall bias
was highly likely because the study was a retrospective
questionnaire survey. Some data may have been pro-
vided based on the memory of the persons who com-
pleted the questionnaire and thus some values may be
inaccurate. Moreover, the surveyed subjects may have
hesitated to report complications and deaths. Although
the response rate to the questionnaire was high, the
facilities with a high complication rate may not have
participated. In Japan, chest radiography is usually
performed following bronchoscopy to confirm the pres-
ence of pneumothorax [15]. However, the follow-up
method to determine the occurrence of complications is
entrusted to each facility and is not standardized. Ac-
cordingly, it is possible that asymptomatic complications
and severe cases treated at other facilities were
overlooked. Moreover, the present survey involved facil-
ities certified by JSRE, and expert operators were in-
cluded. Therefore, the complication rate may have been
underestimated compared with the actual situation. Fur-
thermore, when the complication and damage rates were
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the patients who received EBUS-TBNA.
Conclusion
Although the complication rate for EBUS-TBNA was
found to be low, severe complications and a high inci-
dence of device breakage were observed during the study
period. With the rapid and widespread use of EBUS-
TBNA as a diagnostic method, an educational system pro-
viding clear instructions on how to properly perform the
procedure safely needs to be immediately established.
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